Literature DB >> 23405979

Analysis of D216H polymorphism in Argentinean patients with primary dystonia.

Mariela Caputo1, Maximiliano Irisarri, Claudia Perandones, Evguenia Alechine, Luis Alejandro Pellene, Claudia Uribe Roca, Federico E Micheli, Daniel Corach.   

Abstract

The D216H polymorphism (rs1801968) in TOR1A has been suggested as a risk factor for developing primary dystonia in German subjects not carrying the deletion c.904-906delGAG (∆GAG). However, this association could not be confirmed in other populations with different ethnic backgrounds. The purpose of this study is to evaluate the D216H polymorphism in an Argentinean cohort of 40 patients with primary dystonia and 200 unrelated control subjects. The authors could observe a significantly higher frequency of the H216 variant in dystonic patients lacking ∆GAG as compared with controls.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23405979     DOI: 10.3109/01677063.2012.761697

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  3 in total

1.  Association of TOR1A and GCH1 Polymorphisms with Isolated Dystonia in India.

Authors:  Subhajit Giri; Arunibha Ghosh; Shubhrajit Roy; Charulata Savant Sankhla; Shyamal Kumar Das; Kunal Ray; Jharna Ray
Journal:  J Mol Neurosci       Date:  2020-07-13       Impact factor: 3.444

Review 2.  The Role of TOR1A Polymorphisms in Dystonia: A Systematic Review and Meta-Analysis.

Authors:  Vasileios Siokas; Efthimios Dardiotis; Evangelia E Tsironi; Georgios Tsivgoulis; Dimitrios Rikos; Maria Sokratous; Stylianos Koutsias; Konstantinos Paterakis; Georgia Deretzi; Georgios M Hadjigeorgiou
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

Review 3.  Risk Factor Genes in Patients with Dystonia: A Comprehensive Review.

Authors:  Vasileios Siokas; Athina-Maria Aloizou; Zisis Tsouris; Amalia Michalopoulou; Alexios-Fotios A Mentis; Efthimios Dardiotis
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-01-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.